Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease - PubMed (original) (raw)
. 2003 Oct;17(13):1957-9.
doi: 10.1096/fj.03-0203fje. Epub 2003 Aug 15.
Affiliations
- PMID: 12923073
- DOI: 10.1096/fj.03-0203fje
Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease
Hui-Ming Gao et al. FASEB J. 2003 Oct.
Abstract
Parkinson's disease (PD) is a profound movement disorder resulting from progressive degeneration of the nigrostriatal dopaminergic pathway. Although its etiology remains unknown, increasing evidence suggests the involvement of multiple factors such as environmental toxins and genetic susceptibilities in the pathogenesis of PD. In this study using mesencephalic neuron-glia cultures as an in vitro PD model, we demonstrated that the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP, 0.1-0.5 microM) and an inflammogen lipopolysaccharide (LPS, 0.5 ng/ml) synergistically induced a progressive and selective degeneration of dopaminergic neurons. The synergistic neurotoxicity was observed when both agents were applied either simultaneously or in tandem. The synergistic neurotoxicity was more prominent when lower doses of both agents were applied for a longer period of time. Mechanistically, microglial NADPH oxidase-mediated generation of reactive oxygen species played a pivotal role in the synergistic neurotoxicity: MPTP and LPS synergistically stimulated the NADPH oxidase-mediated release of superoxide free radical; pharmacological inhibition and genetic inactivation of NADPH oxidase prevented superoxide production and the synergistic neurotoxicity. Additionally, inhibition of nitric oxide synthase afforded significant neuroprotection, suggesting the involvement of nitric oxide in the synergistic neurotoxicity. This study lends strong support for a multifactorial etiology of PD and provides clues for therapeutic interventions.
Similar articles
- Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease.
Gao HM, Liu B, Zhang W, Hong JS. Gao HM, et al. FASEB J. 2003 Oct;17(13):1954-6. doi: 10.1096/fj.03-0109fje. Epub 2003 Aug 1. FASEB J. 2003. PMID: 12897068 - Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease.
Gao HM, Hong JS, Zhang W, Liu B. Gao HM, et al. J Neurosci. 2003 Feb 15;23(4):1228-36. doi: 10.1523/JNEUROSCI.23-04-01228.2003. J Neurosci. 2003. PMID: 12598611 Free PMC article. - Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase.
Zhang W, Wang T, Qin L, Gao HM, Wilson B, Ali SF, Zhang W, Hong JS, Liu B. Zhang W, et al. FASEB J. 2004 Mar;18(3):589-91. doi: 10.1096/fj.03-0983fje. Epub 2004 Jan 20. FASEB J. 2004. PMID: 14734632 - Nitric oxide and reactive oxygen species in Parkinson's disease.
Tieu K, Ischiropoulos H, Przedborski S. Tieu K, et al. IUBMB Life. 2003 Jun;55(6):329-35. doi: 10.1080/1521654032000114320. IUBMB Life. 2003. PMID: 12938735 Review. - Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.
Morale MC, Serra PA, L'episcopo F, Tirolo C, Caniglia S, Testa N, Gennuso F, Giaquinta G, Rocchitta G, Desole MS, Miele E, Marchetti B. Morale MC, et al. Neuroscience. 2006;138(3):869-78. doi: 10.1016/j.neuroscience.2005.07.060. Epub 2005 Dec 5. Neuroscience. 2006. PMID: 16337092 Review.
Cited by
- Pesticides, microglial NOX2, and Parkinson's disease.
Taetzsch T, Block ML. Taetzsch T, et al. J Biochem Mol Toxicol. 2013 Feb;27(2):137-49. doi: 10.1002/jbt.21464. Epub 2013 Jan 24. J Biochem Mol Toxicol. 2013. PMID: 23349115 Free PMC article. - Grafted Neural Precursors Integrate Into Mouse Striatum, Differentiate and Promote Recovery of Function Through Release of Erythropoietin in MPTP-Treated Mice.
Carelli S, Giallongo T, Viaggi C, Gombalova Z, Latorre E, Mazza M, Vaglini F, Di Giulio AM, Gorio A. Carelli S, et al. ASN Neuro. 2016 Oct 27;8(5):1759091416676147. doi: 10.1177/1759091416676147. Print 2016 Oct. ASN Neuro. 2016. PMID: 27789613 Free PMC article. - Rotenone directly induces BV2 cell activation via the p38 MAPK pathway.
Gao F, Chen D, Hu Q, Wang G. Gao F, et al. PLoS One. 2013 Aug 20;8(8):e72046. doi: 10.1371/journal.pone.0072046. eCollection 2013. PLoS One. 2013. PMID: 23977201 Free PMC article. - Pathophysiological Role of Transient Receptor Potential Mucolipin Channel 1 in Calcium-Mediated Stress-Induced Neurodegenerative Diseases.
Santoni G, Maggi F, Amantini C, Marinelli O, Nabissi M, Morelli MB. Santoni G, et al. Front Physiol. 2020 Mar 24;11:251. doi: 10.3389/fphys.2020.00251. eCollection 2020. Front Physiol. 2020. PMID: 32265740 Free PMC article. Review. - alpha-Synuclein: a therapeutic target for Parkinson's disease?
Maguire-Zeiss KA. Maguire-Zeiss KA. Pharmacol Res. 2008 Nov-Dec;58(5-6):271-80. doi: 10.1016/j.phrs.2008.09.006. Epub 2008 Sep 16. Pharmacol Res. 2008. PMID: 18840530 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources